Cargando…
Aberrant Expression of Serum MicroRNA-153 and -199a in Generalized Epilepsy and its Correlation with Drug Resistance
BACKGROUND: Epilepsy is one of the common neurological disorders affecting approximately 50 million people worldwide. Despite the recent introduction of new antiepileptic drugs, about one-third of patients with epilepsy have seizures refractory to pharmacotherapy. Early recognition of patients with...
Autores principales: | Zahra, Mai A., Kamha, Eman S., Abdelaziz, Hanan K., Nounou, Howaida A., Deeb, Hany M. El |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101161/ https://www.ncbi.nlm.nih.gov/pubmed/37064282 http://dx.doi.org/10.1177/09727531221077667 |
Ejemplares similares
-
MicroRNAs as Potential Biomarkers for Childhood Epilepsy
por: Elnady, Hala G., et al.
Publicado: (2019) -
MicroRNA-199: A Potential Therapeutic Tool for Hepatocellular Carcinoma in an Experimental Model
por: Atta, Shimaa, et al.
Publicado: (2021) -
Overview of microRNA-199a Regulation in Cancer
por: Wang, Qiwen, et al.
Publicado: (2019) -
Aberrant expression of miR-153 is associated with overexpression of hypoxia-inducible factor-1α in refractory epilepsy
por: Li, Yaohua, et al.
Publicado: (2016) -
MicroRNA-153 Regulates the Acquisition of Gliogenic Competence by Neural Stem Cells
por: Tsuyama, Jun, et al.
Publicado: (2015)